EU Business Round-Up: Galderma Divests To Dallman’s, Oysershell names CEO, Ceres Acquires
Executive Summary
Latest business news in the EU: Galderma offloads German Bübchen brand to Dallman's; Belgium's Oystershell names experienced CEO; Ceres Pharma snaps up Romania's Viva.
You may also be interested in...
Ceres Pharma Expands In Eastern Europe With ABOPharma
Belgium's Ceres Pharma has expanded its footprint in Eastern Europe by acquiring supplements and OTC device specialist ABOPharma.
The Bubble Bursts: Germany’s OTC Market Slumps As COVID-19 Impact Deepens
After an almost 50% rise in sales in March, Germany's OTC market suffered a severe contraction in April as the 'boom' effect of the coronavirus wore off, according to data from Sempora Consulting.
Belgium’s Amophar Acquires Patch Pharma, Launches Pharmacy-Only CBD
Amophar has snapped up Belgian player Patch Pharma and at the same time launched the first pharmacy-only CBD available in the country.